Can losartan (angiotensin II receptor blocker) cause acute pancreatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Losartan Cause Pancreatitis?

Yes, losartan can cause acute pancreatitis, but this is an extremely rare adverse effect, and the overall evidence suggests that angiotensin II receptor blockers (ARBs) like losartan may actually be protective against pancreatitis compared to other antihypertensive medications.

Evidence Assessment

The FDA drug label for losartan does not list pancreatitis as a recognized adverse effect 1. However, isolated case reports document losartan-induced pancreatitis 2, 3, 4, establishing biological plausibility through case reports with positive rechallenge in some instances.

The most important and recent population-based evidence contradicts the case reports:

Large-Scale Population Studies Show Protective Effect

A 2017 Swedish nationwide case-control study of 6,161 acute pancreatitis cases found that ARB use was associated with a 23% decreased risk of acute pancreatitis (adjusted OR 0.77,95% CI 0.69-0.86) compared to non-users 5. This protective effect was significant for both severe (OR 0.71) and mild pancreatitis (OR 0.81).

A 2017 Taiwanese population-based case-control study of 1,449 hypertensive patients with acute pancreatitis found no significant association between losartan use and acute pancreatitis (adjusted OR 0.96,95% CI 0.68-1.37 for current use) 6.

Contrasting Evidence for ACE Inhibitors

Importantly, a 2022 UK population-based cohort study found that ACE inhibitors (not ARBs) were associated with increased pancreatitis risk (HR 1.45,95% CI 1.15-1.83), while ARBs showed no increased risk (HR 0.88,95% CI 0.60-1.31) 7. This distinction is critical—the pancreatitis risk appears specific to ACE inhibitors, not the ARB class that includes losartan.

Clinical Implications

When to Suspect Drug-Induced Pancreatitis

  • Abdominal pain developing after losartan initiation (typically within days to weeks, though delayed onset has been reported 3)
  • Elevated lipase/amylase with imaging confirmation
  • Exclusion of common causes: gallstones, alcohol, hypertriglyceridemia (>500 mg/dL), hypercalcemia, other medications 8

Management Algorithm

  1. If pancreatitis develops on losartan:

    • Discontinue losartan immediately
    • Provide supportive care per standard pancreatitis guidelines 8
    • Symptoms typically resolve within 2-7 days after discontinuation 2
    • Do not rechallenge with losartan
  2. Alternative antihypertensive selection:

    • Consider switching to a different ARB if ARB therapy is still indicated (class effect is uncertain)
    • Calcium channel blockers are safe alternatives 7
    • Avoid ACE inhibitors, which carry higher pancreatitis risk than ARBs 7
  3. For patients with prior pancreatitis:

    • ARBs (including losartan) are not contraindicated based on population data showing protective effects 5
    • Exercise clinical judgment for individual risk-benefit assessment

Important Caveats

The case reports represent idiosyncratic reactions occurring in isolated patients, while the population-level data from thousands of patients shows either no association or a protective effect. The number needed to harm, even if a causal relationship existed, would be extraordinarily high.

Do not withhold losartan solely due to pancreatitis concerns in patients who would otherwise benefit from ARB therapy for hypertension, heart failure, or diabetic nephropathy 9, 10. The cardiovascular and renal benefits far outweigh the theoretical pancreatitis risk.

The mechanism by which ARBs might protect against pancreatitis involves angiotensin II receptors' role in regulating pancreatic microcirculation and secretion 2, though the exact pathophysiology remains incompletely understood.

References

Research

Delayed-Onset Losartan-Induced Pancreatitis Secondary to an Overdose: A Case Report.

Journal of investigative medicine high impact case reports, 2023

Research

No association between losartan use and acute pancreatitis in hypertensive patients.

European journal of hospital pharmacy : science and practice, 2017

Related Questions

In a 26-year-old woman with acute abdominal pain and imaging‑confirmed acute pancreatitis, what further diagnostic work‑up and initial medical management are indicated?
In a young patient in his 20s with recurrent pancreatitis who presents with acute pancreatitis and ultrasound showing gallbladder sludge and a dilated common bile duct without stones, what is the next step to reduce recurrence of pancreatitis?
What is the recommended nutrition strategy for a patient with acute pancreatitis?
In acute pancreatitis, when is an abdominal CT scan with contrast indicated versus a non‑contrast CT?
How should an elevated serum lipase be evaluated to diagnose acute pancreatitis?
What are the radiographic criteria for confirming appropriate nasogastric (NG) tube placement on a chest‑abdomen X‑ray?
Given the MRI findings of a large right paracentral/subarticular disc extrusion at L4‑L5 with severe canal narrowing and moderate‑to‑severe bilateral foraminal narrowing, and assuming failed conservative therapy, do I have a sufficient case for a discectomy that Medicaid is likely to approve?
In patients with gallstone pancreatitis, are antibiotics indicated?
How does renal failure (chronic kidney disease) cause hypertriglyceridemia?
Is an MRI performed four years ago that shows a disc protrusion has not re‑absorbed and has worsened, together with a confirming lab report, sufficient evidence to qualify for spinal surgery without further clinical criteria?
In an 80‑plus‑year‑old woman who developed new blurry vision one hour after taking metoprolol, apixaban (Eliquis) and furosemide (Lasix) that were started two days ago, should these medications be stopped and an urgent ophthalmology assessment arranged?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.